메뉴 건너뛰기




Volumn 33, Issue 12, 2005, Pages 1427-1435

Cellular immune therapy for refractory cancers: Novel therapeutic strategies

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; IDARUBICIN; MELPHALAN; METHOTREXATE; SIPLIZUMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 28844481895     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.06.032     Document Type: Review
Times cited : (14)

References (54)
  • 1
    • 0027263351 scopus 로고
    • Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice
    • F.M. Stewart, R.B. Crittenden, P.A. Lowry, S. Pearson-White, and P.J. Quesenberry Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice Blood 81 1993 2566 2571
    • (1993) Blood , vol.81 , pp. 2566-2571
    • Stewart, F.M.1    Crittenden, R.B.2    Lowry, P.A.3    Pearson-White, S.4    Quesenberry, P.J.5
  • 3
    • 0035863758 scopus 로고    scopus 로고
    • Allogeneic chimerism with low dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice
    • P.J. Quesenberry, S. Zhong, H. Wang, and F.M. Stewart Allogeneic chimerism with low dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice Blood 97 2001 557 564
    • (2001) Blood , vol.97 , pp. 557-564
    • Quesenberry, P.J.1    Zhong, S.2    Wang, H.3    Stewart, F.M.4
  • 4
    • 1542608429 scopus 로고    scopus 로고
    • Murine marrow cellularity and the concept of stem cell competition: Geographic and quantitative determinants in stem cell biology
    • G.A. Colvin, J.F. Lambert, and M. Abedi Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology Leukemia 18 2004 575 583
    • (2004) Leukemia , vol.18 , pp. 575-583
    • Colvin, G.A.1    Lambert, J.F.2    Abedi, M.3
  • 5
    • 0036402128 scopus 로고    scopus 로고
    • H-2 mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation
    • J.F. Lambert, G.A. Colvin, and S. Zhong H-2 mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation Br J Hematol 119 2002 155 163
    • (2002) Br J Hematol , vol.119 , pp. 155-163
    • Lambert, J.F.1    Colvin, G.A.2    Zhong, S.3
  • 6
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogeneous leukemia in marrow transplant patients
    • H. Kolb, J. Mittermuller, and C. Clemm Donor leukocyte transfusions for treatment of recurrent chronic myelogeneous leukemia in marrow transplant patients Blood 76 1990 2462 2465
    • (1990) Blood , vol.76 , pp. 2462-2465
    • Kolb, H.1    Mittermuller, J.2    Clemm, C.3
  • 7
    • 0032605618 scopus 로고    scopus 로고
    • Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions
    • D. Porter, R. Collins, and O. Shilberg Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions Biol Blood Marrow Transplant 5 1999 253 261
    • (1999) Biol Blood Marrow Transplant , vol.5 , pp. 253-261
    • Porter, D.1    Collins, R.2    Shilberg, O.3
  • 8
    • 23444449333 scopus 로고
    • Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia
    • D.L. Porter, M.S. Roth, and C. McGarigle Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia N Engl J Med 330 1994 100 106
    • (1994) N Engl J Med , vol.330 , pp. 100-106
    • Porter, D.L.1    Roth, M.S.2    McGarigle, C.3
  • 9
    • 0032006125 scopus 로고    scopus 로고
    • Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
    • S. Slavin, A. Nagler, and E. Naparstek Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756 763
    • (1998) Blood , vol.91 , pp. 756-763
    • Slavin, S.1    Nagler, A.2    Naparstek, E.3
  • 10
    • 0035895068 scopus 로고    scopus 로고
    • Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
    • I.F. Khouri, R.M. Saliba, and S.A. Giralt Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality Blood 98 2001 3595 3599
    • (2001) Blood , vol.98 , pp. 3595-3599
    • Khouri, I.F.1    Saliba, R.M.2    Giralt, S.A.3
  • 11
    • 20244388936 scopus 로고    scopus 로고
    • Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies
    • T.R. Spitzer, S. McAfee, and B.R. Dey Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies Transplantation 75 2003 1748 1752
    • (2003) Transplantation , vol.75 , pp. 1748-1752
    • Spitzer, T.R.1    McAfee, S.2    Dey, B.R.3
  • 12
    • 0035203625 scopus 로고    scopus 로고
    • Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation
    • B.R. Dey, S. McAfee, and R. Sackstein Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation Biol Blood Marrow Transplant 7 2001 604 612
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 604-612
    • Dey, B.R.1    McAfee, S.2    Sackstein, R.3
  • 13
    • 0035041461 scopus 로고    scopus 로고
    • Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
    • D.L. Porter, S.M. Luger, and K.M. Duffy Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation Biol Blood Marrow Transplant 7 2001 230 238
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 230-238
    • Porter, D.L.1    Luger, S.M.2    Duffy, K.M.3
  • 14
    • 0032960701 scopus 로고    scopus 로고
    • Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancy
    • D.L. Porter, J.M. Connors, and V.M. Van Deerlin Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancy J Clin Oncol 17 1999 1234 1237
    • (1999) J Clin Oncol , vol.17 , pp. 1234-1237
    • Porter, D.L.1    Connors, J.M.2    Van Deerlin, V.M.3
  • 15
    • 0037100412 scopus 로고    scopus 로고
    • Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy
    • K.K. Ballen, P.S. Becker, and R.V.B. Emmons Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy Blood 100 2002 442 450
    • (2002) Blood , vol.100 , pp. 442-450
    • Ballen, K.K.1    Becker, P.S.2    Emmons, R.V.B.3
  • 16
    • 3242774628 scopus 로고    scopus 로고
    • Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: Dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
    • M. De Lima, A. Anagnostopoulos, and M. Munsell Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation Blood 104 2004 865 872
    • (2004) Blood , vol.104 , pp. 865-872
    • De Lima, M.1    Anagnostopoulos, A.2    Munsell, M.3
  • 17
    • 0034648702 scopus 로고    scopus 로고
    • Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation
    • R. Childs, A. Chernoff, and N. Contentin Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation N Engl J Med 343 2000 750 758
    • (2000) N Engl J Med , vol.343 , pp. 750-758
    • Childs, R.1    Chernoff, A.2    Contentin, N.3
  • 18
    • 0842328807 scopus 로고    scopus 로고
    • Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors
    • C. Carballo, N. Geller, and R. Kurlander Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors Blood 103 2004 1560 1563
    • (2004) Blood , vol.103 , pp. 1560-1563
    • Carballo, C.1    Geller, N.2    Kurlander, R.3
  • 19
    • 0036053789 scopus 로고    scopus 로고
    • Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: Results of five patients
    • J.O. Bay, J. Fleury, and B. Choufi Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients Bone Marrow Transplant 30 2000 95 102
    • (2000) Bone Marrow Transplant , vol.30 , pp. 95-102
    • Bay, J.O.1    Fleury, J.2    Choufi, B.3
  • 20
    • 0030061659 scopus 로고    scopus 로고
    • The probability of finding a suitable related donor for bone marrow transplantation in extended families
    • R.F. Schipper, J. D'amaro, and M. Oudshoorn The probability of finding a suitable related donor for bone marrow transplantation in extended families Blood 87 1996 800 804
    • (1996) Blood , vol.87 , pp. 800-804
    • Schipper, R.F.1    D'Amaro, J.2    Oudshoorn, M.3
  • 21
    • 0028785797 scopus 로고
    • Processing and cryopreservation of placental-umbilical cord blood for unrelated marrow reconstitution
    • P. Rubinstein, L. Dobrila, and R.E. Rosenfield Processing and cryopreservation of placental-umbilical cord blood for unrelated marrow reconstitution Proc Natl Acad Sci U S A 92 1995 10119 10122
    • (1995) Proc Natl Acad Sci U S a , vol.92 , pp. 10119-10122
    • Rubinstein, P.1    Dobrila, L.2    Rosenfield, R.E.3
  • 22
    • 0035144564 scopus 로고    scopus 로고
    • Bigger is better: Maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units
    • K.K. Ballen, M. Wilson, and H. Valinski Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units Bone Marrow Transplantat 27 2000 7 14
    • (2000) Bone Marrow Transplantat , vol.27 , pp. 7-14
    • Ballen, K.K.1    Wilson, M.2    Valinski, H.3
  • 23
    • 1842531110 scopus 로고    scopus 로고
    • Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks
    • K.K. Ballen, J. Kurtzberg, and T.A. Lane Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks Biol Blood Marrow Transplant 10 2004 269 275
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 269-275
    • Ballen, K.K.1    Kurtzberg, J.2    Lane, T.A.3
  • 24
    • 8944228913 scopus 로고    scopus 로고
    • Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
    • J. Kurtzberg, M. Laughlin, and M.L. Graham Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients N Engl J Med 335 1996 157 166
    • (1996) N Engl J Med , vol.335 , pp. 157-166
    • Kurtzberg, J.1    Laughlin, M.2    Graham, M.L.3
  • 25
    • 9244256765 scopus 로고    scopus 로고
    • Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
    • M.J. Laughlin, M. Eapen, and P. Rubinstein Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia N Engl J Med 351 2004 2265 2275
    • (2004) N Engl J Med , vol.351 , pp. 2265-2275
    • Laughlin, M.J.1    Eapen, M.2    Rubinstein, P.3
  • 26
    • 0042441121 scopus 로고    scopus 로고
    • Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensitiy conditioning
    • J.N. Barker, D.J. Weisdorf, T.E. Defor, B.R. Blazar, J.S. Miller, and J.E. Wagner Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensitiy conditioning Blood 102 2003 1915 1919
    • (2003) Blood , vol.102 , pp. 1915-1919
    • Barker, J.N.1    Weisdorf, D.J.2    Defor, T.E.3    Blazar, B.R.4    Miller, J.S.5    Wagner, J.E.6
  • 27
    • 12144289378 scopus 로고    scopus 로고
    • Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants
    • A. Daly, S. McAfee, and B. Dey Nonmyeloablative bone marrow transplantation: infectious complications in 65 recipients of HLA-identical and mismatched transplants Biol Blood Marrow Transplant 9 2003 373 382
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 373-382
    • Daly, A.1    McAfee, S.2    Dey, B.3
  • 28
    • 0042738792 scopus 로고    scopus 로고
    • Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)
    • Y. Kanda, S. Chiba, and H. Hirai Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000) Blood 102 2003 1541 1547
    • (2003) Blood , vol.102 , pp. 1541-1547
    • Kanda, Y.1    Chiba, S.2    Hirai, H.3
  • 29
    • 0033594552 scopus 로고    scopus 로고
    • Mixed lymphohematopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation
    • M. Sykes, F. Preffer, and S. McAfee Mixed lymphohematopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation Lancet 353 1999 1755 1759
    • (1999) Lancet , vol.353 , pp. 1755-1759
    • Sykes, M.1    Preffer, F.2    McAfee, S.3
  • 30
    • 28844464619 scopus 로고    scopus 로고
    • Mini-haploidentical transplantation for refractory acute myeloid leukemia
    • G.A. Colvin, M. Abedi, and R. Rathore Mini-haploidentical transplantation for refractory acute myeloid leukemia [abstract] Blood 140 2004 2150a
    • (2004) Blood , vol.140
    • Colvin, G.A.1    Abedi, M.2    Rathore, R.3
  • 31
    • 1842513737 scopus 로고    scopus 로고
    • HLA-haploidentical stem cell infusions for refractory hematologic malignancies: A universal outpatient immunotherapeutic approach in 100 cGy treated patients
    • K. Dicke A. Keating Carden Jennings Publishing Co Charlottesville, VA
    • G.A. Colvin, R. Rathore, and J.F. Lambert HLA-haploidentical stem cell infusions for refractory hematologic malignancies: a universal outpatient immunotherapeutic approach in 100 cGy treated patients K. Dicke A. Keating Autologous Blood and Marrow Transplantation 2003 Carden Jennings Publishing Co Charlottesville, VA 267 277
    • (2003) Autologous Blood and Marrow Transplantation , pp. 267-277
    • Colvin, G.A.1    Rathore, R.2    Lambert, J.F.3
  • 32
    • 0035254219 scopus 로고    scopus 로고
    • Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
    • S. Giralt, P.F. Thall, and I. Khouri Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation Blood 97 2001 631 637
    • (2001) Blood , vol.97 , pp. 631-637
    • Giralt, S.1    Thall, P.F.2    Khouri, I.3
  • 33
    • 18744388971 scopus 로고    scopus 로고
    • High incidence of graft-versus-host disease (GVHD) in nonmyeloablative allogeneic (NMA) stem cell transplants (SCT) with unrelated donors (UD)
    • N. Sacks, G. Orloff, and K. Duffy High incidence of graft-versus-host disease (GVHD) in nonmyeloablative allogeneic (NMA) stem cell transplants (SCT) with unrelated donors (UD) Proc Am Soc Clin Oncol 21 2002 282b
    • (2002) Proc Am Soc Clin Oncol , vol.21
    • Sacks, N.1    Orloff, G.2    Duffy, K.3
  • 34
    • 0034307366 scopus 로고    scopus 로고
    • In vivo CAMPATH-1H prevents graft versus-host disease following nonmyeloablative stem cell transplantation
    • P.D. Kottaridis, D.W. Milligan, and R. Chopra In vivo CAMPATH-1H prevents graft versus-host disease following nonmyeloablative stem cell transplantation Blood 96 2000 2419 2425
    • (2000) Blood , vol.96 , pp. 2419-2425
    • Kottaridis, P.D.1    Milligan, D.W.2    Chopra, R.3
  • 35
    • 0033575383 scopus 로고    scopus 로고
    • Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells
    • W. Shlomchik, M. Couzens, and C. Tang Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells Science 285 5426 1999 412 415
    • (1999) Science , vol.285 , Issue.5426 , pp. 412-415
    • Shlomchik, W.1    Couzens, M.2    Tang, C.3
  • 36
    • 20844438494 scopus 로고    scopus 로고
    • Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation
    • A.W. Loren, S.M. Luger, and E.A. Stadtmauer Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation Bone Marrow Transplant 35 2005 921 926
    • (2005) Bone Marrow Transplant , vol.35 , pp. 921-926
    • Loren, A.W.1    Luger, S.M.2    Stadtmauer, E.A.3
  • 37
    • 0141475940 scopus 로고    scopus 로고
    • Impact of prophylactic donor leukocyte infusion on mixed chimerism, graft-versus-host disease, and antitumor responses in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation
    • B.R. Dey, S. McAfee, and C. Colby Impact of prophylactic donor leukocyte infusion on mixed chimerism, graft-versus-host disease, and antitumor responses in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation Biol Blood Marrow Transplant 9 2003 320 329
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 320-329
    • Dey, B.R.1    McAfee, S.2    Colby, C.3
  • 38
    • 13444310503 scopus 로고    scopus 로고
    • Anti-tumor response despite loss of donor chimerism in patients treated with nonmyeloablative conditioning and allogeneic stem cell transplantation
    • B.R. Dey, S. McAfee, and C. Colby Anti-tumor response despite loss of donor chimerism in patients treated with nonmyeloablative conditioning and allogeneic stem cell transplantation Br J Hematol 128 2005 351 359
    • (2005) Br J Hematol , vol.128 , pp. 351-359
    • Dey, B.R.1    McAfee, S.2    Colby, C.3
  • 39
    • 0033642531 scopus 로고    scopus 로고
    • The intentional induction of mixed chimerism and achievement of anti-tumor responses following non-myeloablative conditioning therapy and HLA-matched donor bone marrow transplant for refractory hematologic malignancies
    • T.R. Spitzer, S. McAfee, and R. Sackstein The intentional induction of mixed chimerism and achievement of anti-tumor responses following non-myeloablative conditioning therapy and HLA-matched donor bone marrow transplant for refractory hematologic malignancies Biol Blood Marrow Transplant 6 2000 309 320
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 309-320
    • Spitzer, T.R.1    McAfee, S.2    Sackstein, R.3
  • 40
    • 0037707801 scopus 로고    scopus 로고
    • Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation
    • A.B. Kraus, J. Shaffer, and H.C. Toh Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation Exp Hematol 31 2003 609 621
    • (2003) Exp Hematol , vol.31 , pp. 609-621
    • Kraus, A.B.1    Shaffer, J.2    Toh, H.C.3
  • 41
    • 0141455935 scopus 로고    scopus 로고
    • Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: Critical role for recipient-derived interferon gamma
    • M.T. Rubio, Y.M. Kim, T. Sachs, M. Mapara, G. Zhao, and M. Sykes Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived interferon gamma Blood 102 2003 2300 2307
    • (2003) Blood , vol.102 , pp. 2300-2307
    • Rubio, M.T.1    Kim, Y.M.2    Sachs, T.3    Mapara, M.4    Zhao, G.5    Sykes, M.6
  • 42
    • 0036624786 scopus 로고    scopus 로고
    • Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer
    • M. Bregni, A. Dodero, and J. Peccatori Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer Blood 99 2002 4234 4236
    • (2002) Blood , vol.99 , pp. 4234-4236
    • Bregni, M.1    Dodero, A.2    Peccatori, J.3
  • 43
    • 0034114495 scopus 로고    scopus 로고
    • Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer
    • J.O. Bay, B. Choufi, and C. Pomel Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer Bone Marrow Transplant 25 2000 681 682
    • (2000) Bone Marrow Transplant , vol.25 , pp. 681-682
    • Bay, J.O.1    Choufi, B.2    Pomel, C.3
  • 44
    • 0031726010 scopus 로고    scopus 로고
    • Costimulatory approaches to adoptive immunotherapy
    • L. Liebowitz, K.P. Lee, and C.H. June Costimulatory approaches to adoptive immunotherapy Curr Opin Oncol 10 1998 533 541
    • (1998) Curr Opin Oncol , vol.10 , pp. 533-541
    • Liebowitz, L.1    Lee, K.P.2    June, C.H.3
  • 45
    • 79960971747 scopus 로고    scopus 로고
    • Graft-vs-tumor induction with donor leukocyte infusions expanded ex-vivo by activation with CD3/CD28 stimulation
    • D. Porter, N. Bunin, and G. Laport Graft-vs-tumor induction with donor leukocyte infusions expanded ex-vivo by activation with CD3/CD28 stimulation [abstract] Blood 98 2001 404a
    • (2001) Blood , vol.98
    • Porter, D.1    Bunin, N.2    Laport, G.3
  • 46
    • 0037702924 scopus 로고    scopus 로고
    • Donor leukocyte infusions in acute myelogeneous leukemia
    • D.L. Porter Donor leukocyte infusions in acute myelogeneous leukemia Leukemia 17 2003 1035 1037
    • (2003) Leukemia , vol.17 , pp. 1035-1037
    • Porter, D.L.1
  • 47
    • 0037080121 scopus 로고    scopus 로고
    • Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem cell transplantation
    • J. Levine, T. Braun, and S. Penza Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem cell transplantation J Clin Oncol 20 2002 405 412
    • (2002) J Clin Oncol , vol.20 , pp. 405-412
    • Levine, J.1    Braun, T.2    Penza, S.3
  • 48
    • 19044363050 scopus 로고    scopus 로고
    • Enhancing graft-vs-tumor (GVT) activity of donor leukocyte infusions by ex-vivo expansion and activation with CD3/CD28 co-stimulation
    • D. Porter, B. Levine, and N. Bunin Enhancing graft-vs-tumor (GVT) activity of donor leukocyte infusions by ex-vivo expansion and activation with CD3/CD28 co-stimulation [abstract] Blood 104 2004 794a
    • (2004) Blood , vol.104
    • Porter, D.1    Levine, B.2    Bunin, N.3
  • 49
    • 0037086131 scopus 로고    scopus 로고
    • Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
    • L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
    • (2002) Science , vol.295 , pp. 2097-2100
    • Ruggeri, L.1    Capanni, M.2    Urbani, E.3
  • 50
    • 3242666031 scopus 로고    scopus 로고
    • Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
    • D. Avigan, B. Vasir, and J. Gong Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses Clin Cancer Res 10 2004 4699 4708
    • (2004) Clin Cancer Res , vol.10 , pp. 4699-4708
    • Avigan, D.1    Vasir, B.2    Gong, J.3
  • 51
    • 2442422156 scopus 로고    scopus 로고
    • Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
    • N. Raje, T. Hideshima, and F.E. Davies Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma Br J Hematol 125 2004 343 352
    • (2004) Br J Hematol , vol.125 , pp. 343-352
    • Raje, N.1    Hideshima, T.2    Davies, F.E.3
  • 52
    • 4444310156 scopus 로고    scopus 로고
    • Bone marrow cells participate in regeneration of skeletal muscle by transdifferentiation to muscle cells
    • M. Abedi, D. Greer, and D. Demers Bone marrow cells participate in regeneration of skeletal muscle by transdifferentiation to muscle cells Exp Hematol 31 suppl 1 2003 134
    • (2003) Exp Hematol , vol.31 , Issue.1 SUPPL. , pp. 134
    • Abedi, M.1    Greer, D.2    Demers, D.3
  • 53
    • 0033557249 scopus 로고    scopus 로고
    • Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice
    • S.K. Nilsson, M.S. Dooner, and H.U. Weier Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice J Exp Med 189 1999 729 734
    • (1999) J Exp Med , vol.189 , pp. 729-734
    • Nilsson, S.K.1    Dooner, M.S.2    Weier, H.U.3
  • 54
    • 0035805055 scopus 로고    scopus 로고
    • Multi-organ, multi-lineage engraftment by a single bone marrow cell
    • D.S. Krause, N.D. Theise, and M.I. Collector Multi-organ, multi-lineage engraftment by a single bone marrow cell Cell 105 2001 369 377
    • (2001) Cell , vol.105 , pp. 369-377
    • Krause, D.S.1    Theise, N.D.2    Collector, M.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.